Cargando…

Combination of Aprepitant, Azasetron, and Dexamethasone as Antiemetic Prophylaxis in Women with Gynecologic Cancers Receiving Paclitaxel/Carboplatin Therapy

BACKGROUND: The aim of this study was to evaluate the antiemetic effect of aprepitant and to determine how to provide triple combination therapy (aprepitant/azasetron/dexamethasone) to women receiving paclitaxel/carboplatin moderately emetogenic chemotherapy (MEC). MATERIAL/METHODS: The current stud...

Descripción completa

Detalles Bibliográficos
Autores principales:	Koshiyama, Masafumi, Matsumura, Noriomi, Imai, Saeko, Yamanoi, Koji, Abiko, Kaoru, Yoshioka, Yumiko, Yamaguchi, Ken, Hamanishi, Junzo, Baba, Tsukasa, Konishi, Ikuo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	International Scientific Literature, Inc. 2017
Materias:	Clinical Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5322867/ https://www.ncbi.nlm.nih.gov/pubmed/28198358 http://dx.doi.org/10.12659/MSM.899741

Ejemplares similares

Genomic profile predicts the efficacy of neoadjuvant chemotherapy for cervical cancer patients
por: Horikawa, Naoki, et al.
Publicado: (2015)

Suppression of ABHD2, identified through a functional genomics screen, causes anoikis resistance, chemoresistance and poor prognosis in ovarian cancer
por: Yamanoi, Koji, et al.
Publicado: (2016)

PD-1/PD-L1 blockade in cancer treatment: perspectives and issues
por: Hamanishi, Junzo, et al.
Publicado: (2016)

Groin lymph node detection and sentinel lymph node biopsy in vulvar cancer
por: Sakae, Chieko, et al.
Publicado: (2016)

Metabolic alterations caused by HNF1β expression in ovarian clear cell carcinoma contribute to cell survival
por: Amano, Yasuaki, et al.
Publicado: (2015)

Peritoneal dissemination of high-grade serous ovarian cancer: pivotal roles of chromosomal instability and epigenetic dynamics
por: Konishi, Ikuo, et al.
Publicado: (2022)

Clinical approaches to treating papillary squamous cell carcinoma of the uterine cervix
por: Nagura, Michikazu, et al.
Publicado: (2014)

Recurrence of a carcinoid tumor of the ovary 13 years after the primary surgery: A case report
por: AMANO, YASUAKI, et al.
Publicado: (2013)

Clinical efficacy of neoadjuvant chemotherapy with irinotecan (CPT-11) and nedaplatin followed by radical hysterectomy for locally advanced cervical cancer
por: Abou-Taleb, Hisham A, et al.
Publicado: (2016)

Acquisition of a side population fraction augments malignant phenotype in ovarian cancer
por: Yamanoi, Koji, et al.
Publicado: (2019)

Combination of gene set signatures correlates with response to nivolumab in platinum-resistant ovarian cancer
por: Murakami, Ryusuke, et al.
Publicado: (2021)

Comprehensive assessment of the expression of the SWI/SNF complex defines two distinct prognostic subtypes of ovarian clear cell carcinoma
por: Abou-Taleb, Hisham, et al.
Publicado: (2016)

Anti-VEGF therapy resistance in ovarian cancer is caused by GM-CSF-induced myeloid-derived suppressor cell recruitment
por: Horikawa, Naoki, et al.
Publicado: (2020)

Distinct preoperative clinical features predict four histopathological subtypes of high-grade serous carcinoma of the ovary, fallopian tube, and peritoneum
por: Ohsuga, Takuma, et al.
Publicado: (2017)

Snail promotes ovarian cancer progression by recruiting myeloid-derived suppressor cells via CXCR2 ligand upregulation
por: Taki, Mana, et al.
Publicado: (2018)

Unenhanced region on magnetic resonance imaging represents tumor progression in uterine carcinosarcoma
por: Inoue, Ayami, et al.
Publicado: (2017)

Efficacy of triple antiemetic therapy (palonosetron, dexamethasone, aprepitant) for chemotherapy-induced nausea and vomiting in patients receiving carboplatin-based, moderately emetogenic chemotherapy
por: Miya, Toshimichi, et al.
Publicado: (2016)

The effect of the type of dietary protein on the development of ovarian cancer
por: Taha, Ahmed A.A., et al.
Publicado: (2018)

PDK2 leads to cisplatin resistance through suppression of mitochondrial function in ovarian clear cell carcinoma
por: Kitamura, Sachiko, et al.
Publicado: (2021)

Clinical Efficacy of Ovarian Cancer Screening
por: Koshiyama, Masafumi, et al.
Publicado: (2016)

Recent Concepts of Ovarian Carcinogenesis: Type I and Type II
por: Koshiyama, Masafumi, et al.
Publicado: (2014)

Subtypes of Ovarian Cancer and Ovarian Cancer Screening
por: Koshiyama, Masafumi, et al.
Publicado: (2017)

Adult granulosa cell tumors of the ovary: a retrospective study of 30 cases with respect to the expression of steroid synthesis enzymes
por: Kitamura, Sachiko, et al.
Publicado: (2017)

VISTA expressed in tumour cells regulates T cell function
por: Mulati, Kumuluzi, et al.
Publicado: (2018)

Combination of palonosetron, aprepitant, and dexamethasone as primary antiemetic prophylaxis for cisplatin-based chemotherapy
por: Yang, Chan-Keng, et al.
Publicado: (2016)

B7-H3 Suppresses Antitumor Immunity via the CCL2–CCR2–M2 Macrophage Axis and Contributes to Ovarian Cancer Progression
por: Miyamoto, Taito, et al.
Publicado: (2022)

CXCL13-producing CD4(+) T cells accumulate in the early phase of tertiary lymphoid structures in ovarian cancer
por: Ukita, Masayo, et al.
Publicado: (2022)

ASGO 2nd International Workshop on Gynecologic Oncology
por: Matsumura, Noriomi, et al.
Publicado: (2013)

Adding aprepitant to palonosetron does not decrease carboplatin-induced nausea and vomiting in patients with gynecologic cancer
por: Watanabe, Yuko, et al.
Publicado: (2021)

Low-Grade Endometrial Stromal Sarcoma with a Nodule-in-Nodule Appearance in Preoperative Magnetic Resonance Images
por: Nakamura, Mitsuhiro, et al.
Publicado: (2020)

Corrigendum to “Low-Grade Endometrial Stromal Sarcoma with a Nodule-in-Nodule Appearance in Preoperative Magnetic Resonance Images”
por: Nakamura, Mitsuhiro, et al.
Publicado: (2021)

Comparison of Azasetron and Ondansetron for Preventing Postoperative Nausea and Vomiting in Patients Undergoing Gynecological Laparoscopic Surgery
por: Yun, Mi Ja, et al.
Publicado: (2010)

Antiemetic regimen with aprepitant in the prevention of chemotherapy-induced nausea and vomiting: An updated systematic review and meta-analysis
por: Qiu, Tingting, et al.
Publicado: (2020)

The efficacy of secondary cytoreductive surgery for recurrent ovarian, tubal, or peritoneal cancer in Tian-model low-risk patients
por: So, Makiko, et al.
Publicado: (2019)

Utility of Homologous Recombination Deficiency Biomarkers Across Cancer Types
por: Takamatsu, Shiro, et al.
Publicado: (2021)

Utility of Homologous Recombination Deficiency Biomarkers Across Cancer Types
por: Takamatsu, Shiro, et al.
Publicado: (2022)

Mutation burden-orthogonal tumor genomic subtypes delineate responses to immune checkpoint therapy
por: Takamatsu, Shiro, et al.
Publicado: (2022)

Stability of azasetron-dexamethasone mixture for chemotherapy-induced nausea and vomiting administration
por: Fang, Bao-Xia, et al.
Publicado: (2017)

UGT1A1 polymorphism has a prognostic effect in patients with stage IB or II uterine cervical cancer and one or no metastatic pelvic nodes receiving irinotecan chemotherapy: a retrospective study
por: Matsuoka, Hideki, et al.
Publicado: (2020)

Combination of aprepitant, palonosetron and dexamethasone as antiemetic prophylaxis in lung cancer patients receiving multiple cycles of cisplatin-based chemotherapy
por: Longo, F, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_ftus8j0pshesgfqtjfobvj56q8